HLL Lifecare 在 2024-25 财年向印度政府支付了创纪录的 69.53 亿卢比股息，这得益于强劲的财务增长和扩大了获得负担得起的药物的机会。 HLL Lifecare paid a record ₹69.53 crore dividend to India’s government in FY 2024-25, driven by strong financial growth and expanded access to affordable medicines.

印度政府的医疗保健公司HLL Lifecare在2024-25财年向印度政府支付了创纪录的69.53亿卢比的股息,这反映了强的财务表现,收入增长了20%,达到4,500亿卢比,净资产增加到1,100亿卢比. HLL Lifecare, a government-owned healthcare company, paid a record ₹69.53 crore dividend to the Indian government for FY 2024-25, reflecting strong financial performance with a 20% revenue increase to ₹4,500 crore and net worth rising to ₹1,100 crore. 包括子公司在内的HLL集团报告说,合并收入为4 900卢比,逐年增长19%。 The HLL Group, including subsidiaries, reported ₹4,900 crore in consolidated revenue, up 19% year-on-year. 该公司通过AMRIT制药公司继续扩大获得负担得起的药品的机会,在过去十年中,这些制药公司为6.7亿农民提供了服务,节省了8,000桶自掏腰包费用。 The company continues expanding access to affordable medicines through AMRIT Pharmacies, which have served over 6.7 crore people and saved ₹8,000 crore in out-of-pocket expenses over the past decade.